During the past decade, Schwarzwald-Baar Klinikum, Frauenklinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schwarzwald-Baar Klinikum, Frauenklinik" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "German Cancer Aid" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Schwarzwald-Baar Klinikum, Frauenklinik" are "Cancer of Endometrium Stage I" (1 trials), "Cancer of Endometrium Stage II" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Schwarzwald-Baar Klinikum, Frauenklinik" in a lesser frequency.

Most popular intervention types in "Schwarzwald-Baar Klinikum, Frauenklinik" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "Standard surgical procedure for endometrial cancer" (1 trials), "T-DM1" (1 trials) and "systematic lymphadenectomy (LNE)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schwarzwald-Baar Klinikum, Frauenklinik" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Schwarzwald-Baar Klinikum, Frauenklinik". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Schwarzwald-Baar Klinikum, Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schwarzwald-Baar Klinikum, Frauenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".